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Change in energy reserves in different segments of the nephron during
brief ischemia. Rat kidneys were made ischemic for 5 to 120 seconds.
Segments of individual nephrons were dissected from freeze dried
sections and analyzed for ATP, phosphocreatine, glycogen, glucose,
glucose-6-phosphate, lactate and creatine kinase. ATP fell most rapidly
in proximal convoluted and straight tubules (PCT, PST) and distal
convoluted tubules (DCT), and most slowly in glomerulus and papilla.
Phosphocreatine levels ranged fivefold and was highest in DCT, where
it approached that of brain. Creatine kinase ranged 100-fold with lowest
level in PCT, where the ischemic fall in phosphocreatine was so slow as
to suggest a function other than that of an energy reserve. Glycogen
varied tenfold from modest levels in distal segments to very low levels
in PST, and was not used rapidly in any segment. Glucose consumption
and lactate production were most rapid in distal portions. High—energy
phosphate consumption for the first 7.5 seconds of ischemia, calculated
from these data, indicates roughly—equal energy metabolism in proxi-
mal and distal segments, with lower levels in papilla, and especially in
glomerulus. The absolute values suggest that the in vivo metabolic rate
of the nephron continued almost unabated for 5 or 10 seconds of
ischemia.
The kidney nephron consists of a series of organs with
striking differences in structure, function and enzymatic com-
position. Less is known about differences in energy metabo-
lism, although it is inferred from their enzyme content [1, 2] that
proximal segments have a high oxidative metabolism and distal
segments, a relatively—high glycolytic metabolism. This infer-
ence is supported by in vitro studies of kidney slices from
regions enriched in proximal or distal tubules [3]. It has also
recently been demonstrated by Bagnasco et al [4] that in vitro
lactate production of the distal tubule and collecting ducts far
exceeds that of the proximal tubule.
Energy metabolism in the kidney is of particular interest
because of its exceptionally high value. The kidney shares with
brain the highest metabolic rate in the body, (with the exception
of maximally working muscle). Probably because of its high
metabolic rate, the kidney is particularly sensitive to anoxia and
ischemia. Moreover, some parts of the nephron are more
sensitive to these insults than others. For example, the medul-
lary thick ascending limb of Henle is particularly susceptible to
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damage from anoxia if filtration continues [5]. Paradoxically,
during ischemia it is the S3 segment of the proximal tubule that
is particularly vulnerable [6]. It should therefore be useful to
have information about metabolite changes and energy expen-
diture in specific segments of the nephron in both of these
conditions.
This study deals with one of them. It presents the results of
analyses of six regions of the nephron and the papilla from
kidneys subjected to 5 seconds to 120 seconds of complete
ischemia. Identified segments of individual nephrons were
dissected from freeze dried sections of fast frozen kidneys for
analysis. The changes observed in ATP, phosphocreatine,
glucose, glycogen and lactate permit assessment of segmental
differences in in situ glycolytic and glycogenolytic capacity and
in demand for high energy phosphate.
Methods
Animals
Male Sprague—Dawley rats weighing 300 to 350 g were used.
They were given trypan blue (0.1 mglg) intraperitoneally 18 to
24 hours before the experiment. This dye specifically stains
proximal convoluted tubules and aids visualization for dissec-
tion [7].
Kidney samples
Brief light ether anesthesia was used, usually three minutes
overall. Kidneys were plunged into Freon-12 (CC12F2) (chilled
in liquid N2 to its freezing point) within one second after
removal or after incubation under mineral oil at 37°C for 5 to 120
seconds. The frozen kidneys were stored at —80°C until pre-
pared for analysis. Blocks of tissue were mounted and sec-
tioned at 16 tm without allowing the temperature to rise above
—20°C. The sections were freeze dried at —35°C under vacuum
and stored at —80°C under vacuum.
The general technique for isolation and weighing small iden-
tified samples has been described in detail and the application to
microtome sections reported [8]. Various parts of the nephron
were identified as described before [9] by characteristic size,
color, and texture. Samples consisted of either a central slice of
a glomerulus, a 75 to 150 jim length of tubule, or a patch from
the papilla below the inner stripe of the medulla. Proximal
segments were from the early part of the convoluted tubule
(PCT, deeply stained with trypan blue) or early or late portions
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Table 1. Flow chart for assays
Step I Step 2 Step 3 Step 4 Step 5 Step 6 Step 7
Standards
M
ATP 0.1 p1
0.1 M NaOHa
0.2 1.d
SpR
RT 20 mm
0.2 ,d
0.15 M NaOH°
5 1.d TCR
RT 2 hr
30,000X
1 p1
1 M NaOHa
5 p1 into 1 ml
6PG Rgt
0.5-2
Phospho-
creatine
0.05 p1
0.02 M NaOHa
0.05 p1C
ATP Rgt
RI 20 mm
0.2 cs1
SpR
RI 30 mm
0.2 p1
0.2 M NaOH°
5 p1 TCR
RT 15 hr
120,000X
1 p1
I M NaOHa
5 p1 into I ml
6PG Rgt
0.5—2
Glycogen 0.2 p1
0.02 M NaOH°
0.2 csl
SpR
RT 30 mm
0.2 p1
GIc Rgt
RT 15 mm
0.2 p1
0.2 M NaOHa
7.5 p1 TCR
38° 2 hr
60,000X
2 p1
1 M NaOHa
7 p1 into I ml
6PG Rgt
0.1—1
Glucose 0,1 p1
0.02 M HCIb
0.3 p1
SpR
RT 20 mm
0.2 jd
0.12 M NaOHa
5 p1 ICR
38° 1 hr
15,000X
I p1
0.5 M NaOHa
5 p1 into 1 ml
6PG Rgt
1—5
Glucose-6-
phosphate
0.05 p1
0.02 M HCIb
0.1 d
SpR
RT 30 mm
0.1 p1
0.1 M NaOHa
1 p1 TCR
RT 20 hr
200,000X
10 p1
0.05 M NaOHa
10 p1 into 1 ml
6PG Rgt
0.05—0.2
Lactate 0.05 p1
0.02 M NaOHa
0.1 p.1
SpR
RT 30 mm
3 p1
0.05 M NaOH°
3 p1 into 50 p1 DCR
25° 60 min°
95° 3 mm I ml
mal Rgt
2—10
Creatine-
kinase
5 p1 SpR
20°, 60 mm
5 p.1
0.12 M NaOHa
5 p1 into 50 p1
50 p1
ICR I hr'
95° 3 mm 1 ml
6PG Rgt
50—150
(ATP)
Abbreviations are: Rgt, reagent; SpR, specific reagent; ATP Rgt, ATP removing Rgt; Gic Rgt, glucose Rgt; TCR, NADP cycling reagent; DCR,
NAD cycling reagent; 6PG Rgt, 6-phosphogluconate measuring Rgt; Mal Rgt, malate measuring reagent.
a Heated 20 mm at 80°C
b Heated 20 mm at 60°C
C 0.05 p1 of 0.15 M HCI added and left 10 mm or more at room temperature to destroy NADPH before proceeding
d 3000X for PCT and PST, 400X for other structures
5000X
Concentrations in the first reagent
of the straight tubule (PSTE or PSTL). Distal segments were
from the medullary thick ascending limb of Henle (TAL) or the
convoluted segment (DCT). The samples (5 to 40 ng dry wt)
were weighed 2% on a quartz fiber balance [8]. The value for
each structure of each kidney is based on three to 10 replicate
assays.
Analytical methods
Enzymes were obtained from Sigma Chemical Co. (St. Louis,
Missouri, USA) or Boehringer—Mannheim (Ridgefield, Con-
necticut, USA) except beef heart lactic dehydrogenase which
was from Cooper Biomedical. Most of the other biochemicals
were from Sigma. All reagents were of analytical grade.
Obviously the amounts of the various metabolites per sample
were very small. Control levels ranged from 2 x l0 15mol for
glucose-6-phosphate to l02 mol for glucose. Nevertheless,
except in the case of lactate, no special precautions were
required other than those demanded for analytical precision at
any level. Reagents of analytical grade did not require special
treatment, except in the few instances noted. This is largely due
to the analytical amplification by enzymatic cycling which is
used in each assay. This reduces trace impurities to insignifi-
cance, relative to the substance specifically measured.
The methods were based on art enzyme reaction or sequence
of reactions which result in oxidation or reduction of a pyridine
nucleotide. Sensitivity is then highly amplified by using the
pyndine nucleotide product to catalyze a two—step enzyme
reaction ["enzymatic cycling", 8]. Improved cycling methods
were used for NAD [10] and NADP [11]. These papers may be
consulted for details including composition of the "indicator
reagents", that is, the 6-phosphogluconate and malate measur-
ing reagents of Table 1.
In general the assays were patterned after those developed
for single muscle fibers [12]. A major difference is that extrac-
tion into HC1O4 was omitted. The weighed sample was loaded
through oil into a small droplet of NaOH or HC1 in one of 60
shallow wells drilled in a Teflon block [8] (DuPont, Wilmington,
Delaware, USA). The loaded block was heated to destroy tissue
enzymes. The necessary reagents were then added in sequence
as required, with final transfer from the oil well to a fluorometer
tube for last step(s) and ultimate fluorescence reading.
Table 1 is a flow chart for the assays. The composition of
specific reagents and explanatory notes are as follows.
ATP
The specific reagent contained 140 mrt Tris-HCI buffer, pH
8.1, 300 p.M glucose, 2 m MgCI2, 75 p.M NADP, 0.06%
bovine serum albumin (BSA), 0.4 mri dithiothreitol, 10 pglml
yeast hexokinase (EC 2,7.1.1.) and 5 p.g/ml of 30% pure yeast
glucose-6-phosphate dehydrogenase (EC 1.1.1.49).
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Phosphocreatine
Tissue ATP must be removed before measuring phosphocre-
atine, since ATP formation is part of the analytical reaction
sequence. This removal was done with an "ATP rgt" (Table 1),
similar to the specific reagent of the ATP assay. Its composition
was 70 m Tris-HC1 buffer, pH 8.1, 350 jM glucose, 2 mM
MgCl2, 80 M NADP, 0.08% BSA, 10 g/ml hexokinase, 4
gJml glucose-6-phosphate dehydrogenase and 300 M ADP.
The ADP is included since it is required for the specific enzyme
step, and this pretreatment provides a convenient way to
remove contaminating ATP, which is nearly always present in
commercial ADP.
The specific reagent for phosphocreatine contained 125 mM
imidazole-HC1 buffer, pH 7.0, 90 M glucose, 3 mM MgC12, 80
/.LM NADP, 0.05% BSA, 0.2 mri dithiothreitol, 2 mrs EDTA,
200 pg/ml muscle creatine kinase (EC 2.9.3.2), 12 /Lg/ml
hexokinase, and 8 zJm1 glucose-6-phosphate dehydrogenase.
Glycogen
The specific reagent hydrolyzes glycogen to glucose at an
acid pH. A second reagent (Glc Rgt) then converts glucose at
pH 8 to 6-phosphogluconate, forming NADPH. This is a
modification of a procedure [13] based on the method of Lust,
Passonneau and Lowry [14].
The specific reagent contained 100 m sodium acetate buffer,
pH 4.6 (base:acid, 1:1), 0.04% BSA and 4 jg/ml of amylo-1,4-
glucosidase (EC 3.2.1.3) from Aspergillus niger. The GIc Rgt
contained 100 mM Tris-HC1 buffer, pH 8.7 (base:acid, 4:1), 1
mM ATP, 100 pM NADP, 6 mri MgCI2, 0.07% BSA, 1 mM
dithiothreitol, 1.5 mrvi EDTA, 8 pg/m1 hexokinase, and 2 g/ml
glucose-6-phosphate dehydrogenase.
The mixture of the acetate and Tris buffers yields a pH of
about 8. For distal structures, which contain relatively high
glycogen, the reagent volumes for steps 2—4 were increased
fivefold (to 1 id), and the cycling amplification was reduced
from 60,000 to 20,000-fold.
Glucose
The specific reagent contained 75 mr.i Tris-HCI buffer, pH
8.1, 140 tM ATP, 24 M NADP, 2 mri MgC12, 0.06% BSA, 0.4
mM dithiothreitol, 8 g/ml hexokinase, and 4 g/ml glucose-6-
phosphate dehydrogenase.
Glucose-6-phosphate
The specific reagent contained 75 m Tris-HC1, pH 8.1, 15
/.LM NADP, 0.07% BSA, 0.4 m dithiothreitol, and 6 ig/ml
glucose-6-phosphate dehydrogenase. Note that because of the
very low levels of this metabolite, particularly during ischemia,
very high amplification was required (200,000-fold), which
necessitated a 20 hour incubation at the cycling step (Table 1).
Lactate
The specific reagent contained 100 mM 2-amino-2-methyl-l-
propanol buffer, pH 9.8, 0.5 mi NAD, 0.5 m monosodium
glutamate, 0.05% BSA, 50 sg/ml beef heart lactate dehydrog-
enase (EC 1.1.1,28) and 100 Wml alanine transaminase (EC
2.6.1.2). The glutamate and transaminase were added to pull the
reaction to completion by removing the pyruvate formed.
Lactate contamination can be very troublesome because of
the extremely high levels on the hands. All glassware was
carefully rinsed just before use and gloves worn in making up
the reagents and in handling reaction vessels.
Crea tine kinase
The method is adapted from an earlier procedure used for
assay of single muscle fibers [15], primarily to introduce an
enzymatic cycling step.
The specific reagent contained 100 ifiM imidazole acetate
buffer, pH 6.8, 10 mi phosphocreatine, 1 mri ADP, 3 mM
glucose, 200 M NADP, 15 mM magnesium acetate, 10 mM
AMP, 20 j.tM P', P5-di(adenosine-5')pentaphosphate, 0.5 mM
EDTA, 5 m dithiothreitol, 0.02% BSA, 15 tg/ml hexokinase,
and 1 g/ml glucose-6-phosphate dehydrogenase from Leucon-
ostoc mesenteroides.
The reagent is almost identical to that used before, except for
the addition of the diadenosine pentaphosphate, which is a
potent inhibitor of adenylate kinase [16]. The AMP, which had
been included in the original reagent for the same purpose, was
retained. The procedure has been altered to measure the much
lower activities in the nephron by introducing the enzymatic
cycling amplification steps.
There was found to be a small "tissue blank", that is, a
measurable increase in the final reading if tissue was incubated
with reagent lacking phosphocreatine. This was therefore mea-
sured for each structure and the results corrected accordingly,
although the difference was insignificant except in the case of
the proximal tubule segments, where the blank was substan-
tially larger than the contribution from creatinine kinase itself.
Results
ATP, phosphocreatine and creatine kinase
Normal values. As has been shown before [17], ATP levels
vary about twofold along the nephron from about 10 mmol kg1
(dry wt) in the glomerulus, proximal tubule segments, and
papilla to 16 to 17 mmol kg' in distal tubule segments (Figs. 1,
2, Table 2).
Phosphocreatine. Phosphocreatine is more variable than
ATP, ranging fivefold from about 2 mmol kg in the proximal
straight tubule (PST), thick ascending limb of Henle (TAL) and
papilla to 10 mmol kg' in the distal convoluted tubule (DCT)
(Figs. 1, 3, Table 2). In contrast to ATP, phosphocreatine is
about three times higher in the glomerulus and proximal con-
voluted tubule (PCT) than in the PST, and only a fifth as high in
the TAL as in the DCT.
Creatine kinase. Creatine kinase was also measured in the
same nephron structures (Fig. 1), because of major differences
in the rate of ischemic change in phosphocreatine among the
different structures. Surprisingly, the activity of this enzyme
was found to vary 100-fold from a high in DCT to a low in PCT.
Moreover, activities were completely unrelated to phosphocre-
atinine levels, except that one of the highest levels was in the
DCT where phosphocreatine concentration also reached its
peak. Nevertheless, this peak creatine kinase level is only about
5% of that in rat skeletal muscle and 20% of that in brain.
Changes with ischemia. ATP, on a percentage basis, fell most
rapidly in the proximal rnbule segments, dropping about 50% in
the first five seonds, and leveling off after 30 seconds at about
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0
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20% of control (Fig. 2). The initial change was about as rapid in
the DCT, but subsequent change was slow and the level at 45
seconds was still half of control. In TAL there was an initial
30% drop with no further change by 45 seconds, but with
another drop to 20% of control by 120 seconds. The decreases
in TAL at 7.5 seconds and 45 seconds were significantly smaller
(P <0.05) than for either PCT or PST. ATP underwent minimal
changes in glomerulus and papilla; the levels at 120 seconds
were still 70% and 85% of control, respectively.
Phosphocreatine fell more slowly than ATP in PCT and PST,
and more rapidly than ATP in glomerulus and papilla (Fig. 2,
Table 1). The rates were similar to each other in TAL and DCT.
By 120 seconds the decrease in phosphocreatine, on a percent-
age basis, was as great or greater than that of ATP in all
structures except the PCT. A greater change in phosphocre-
atine than in ATP would be anticipated on the basis of the
equilibrium constant of the creatine kinase reaction. An expla-
nation for the delay in phosphocreatine change in the proximal
tubule may be the extremely low level of creatine kinase in that
portion of the nephron.
Glycogen and glucose
(These metabolites are considered together since they both
are potential sources of lactate and therefore high energy
phosphate during ischemia.)
Control levels. Glycogen was very low in the proximal
segments but higher by a factor of 10 in TAL and papilla (Fig.
4, Table 2). Limited data for DCT indicated a glycogen level in
the same range as the TAL. The glomerulus contained glycogen
at about half the level of the TAL. We are not aware of previous
data on glycogen in nephron segments, but Needleman, Pas-
sonneau and Lowry [18] measured this metabolite in successive
subdivisions of rat kidney from cortex to papilla and found
Fig. 2. Effect of ischemia on ATP levels in 6 parts of the nephron and
in the papilla. Concentrations are mmol . kg' (dry wt). Except as
indicated, each value is the average for 3 to 8 kidneys. The 7.5 and 45
sec values are the averages of data for 5 and 10 sec, and 30 and 60 sec
periods of ischemia respectively. Symbols are: (A) DCT, (0) TAL, (•)
PAP, (0) glom, (•) PST, and (x) PCT.
levels that would be about as expected from the component
nephron structures present in each subdivision. For example,
glycogen concentrations in the outermost and innermost layers
were about 5 and 18 mmol kg (dry wt), respectively.
Glucose varied along the nephron much less than glycogen in
control kidney, with highest levels in the glomerulus and DCT,
and lowest in PST, TAL and PAP (Fig. 5, Table 2). The
concentration in PCT was significantly higher than in the PST.
This normal distribution agrees well with that reported earlier
[19].
Changes in glycogen and glucose with ischemia. There were
no significant changes in glycogen during the first 45 seconds of
ischemia in any of the nephron portions, except for a drop in the
PCT which was very small in absolute terms (Fig. 4, Table 1).
By 120 seconds the levels had fallen at most by a third, but only
the decreases in glomerulus, PCT and TAL were statistically
significant (P < 0.05).
Glucose decreased significantly (P < 0.05) in all regions
except PSTL during 120 seconds of ischemia by amounts
ranging from 24% in PSTE to 93% in TAL (Fig. 5, Table 2). The
average decrease for the three distal portions (TAL, DCT and
papilla) was 69%, whereas in the proximal portions (glomer-
ulus, PCT and PST) the decrease averaged only 27%. The most
rapid change occurred in TAL: 40% in 7.5 seconds, the only
structure showing a significant decrease at this time (P < 0.05).
By 45 seconds, levels in the three distal portions had fallen an
average of 43% (P < 0.01 for TAL and DCT), whereas in the
proximal portions the average decrease was only 7%.
It should be useful to compare the contributions of glucosyl
units to the metabolic pool from glycogen and glucose during
ischemia. During the full 120 seconds the contribution from
glucose exceeded that from glycogen in all regions. In the
proximal structures the contribution from glycogen was espe-
cially small: 15% in the case of the glomerulus, 10% in PCT and
glom PCT PSTE PSTL TAL DCT
Fig. 1. Distribution of ATP (0—0), phosphocreatine (• •), and
creatine kinase (x----x) along the nephron and in the papilla as
percentages of peak values. The peak levels were 17.4 and 10.1
mmole . kg (dry wt) for ATP and phosphocreatine, respectively, and
18.0 1.2 (sE) mole kg (dry wt) h at 20°C for creatine kinase. The
minimum activity for creatine kinase was 0.17 0.12 mole kg hr
in PCT.
Time, sec
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Table 2. Effect of ischemia on metabolite levels in different segments of the nephron
Ischemia
sec Glomerulus PCT PSTE PSTL TAL DCT PAP
ATP 0
7.5
45
120
(5)
(8)
(6)
(3)
9.5 0.5
9.5 0.9
9.1 1.0
6.8 0.3
11.2 1.4
4.38 0.58
1.93 0.16
1.24 0.20
10.1 1.2
4.23 0.85
1.82 0.14
1.85 0.14
9.4 1.4
4.02 0.69
2.45 0.15
1.65 0.21
14.8 1.4
10.8 0.4
10.8 1.8
3.16 0.39
17.4 2.1
7.8 1.0
9.3 1.2
5.7 1.1"
8.6 0.4
10.5 0.7
10.2 1.2
7.2 0.6
Phosphocreatine 0
7.5
45
120
(5)
(7)
(6)
(3)
4.37 0.40
4.29 0.37
1.98 0.32
0.83 0.05
5.15 0.20
6.11 0.42
4.59 0.34
2.76 0.13
1.67 0.56
1,45 0.24
1.33 0.22
0.12 0.02
1.76 0.69
1.47 0.27
1.08 0.21
0.07 0.03
2.18 0.64
1.65 0.16
1.31 0.18
0.31 0.01
10.1 0.3"
7.3 0.7
3.95 0.44
2.59 0.0l'
2.02 0.58
2.56 0.38
2.38 0.43
0.80 0.08
Glycogen 0
7.5
45
120
(5)
(8)
(8)
(3)
7.9 0.4
9.3 0.7
9.9 1.2
5.2 0.6
2.48 0.32
1.42 0.24
1.56 0.16
1.19 0.09
1.81 0.34
1.50 0.23
1.56 0.13
1.76 0.27
1.83 0.18
1.73 0.26
1.30 0.10
1.78 0.60
21.2 0.4
24.6 2.7
20.4 3.9
14.2 2.3
18.7 2.9
21.6 2.5
21.1 2.1
14.0 1.4
Glucose 0
7.5
45
120
(5)
(7)
(7)
(3)
35.7 2.9
33.6 1.1
30.4 2.0
23.2 1.1
31.8 3.4
29.1 0.4
29.8 2.2
21.9 1.3
23.5 2.0
26.0 1.3
25.8 1.7
17.8 0.4
20.6 2.2
22.9 2.1
20.1 2.6
16.7 0.5
20.5 3.0
12.3 2.5
6.3 2.1
1.4 0.3
41.2 2.5
33.6 4.9
28.6 1.3
18.6c
20.4 3.0
20.8 0.8
14.4 2.1
8.1 2.0
Glucose-6- 0 (4) 0.589 0.039 0.125 0.018 0.314 0.013 0.502 0.060 0.304 0.055 0.321 0.040
phosphate 7.545
120
(7)
(6)
(3)
0.488a
0,390b
0.193 0.013
0.133 0.038
0.071 0.006
0.060 0.012
0.201 0.047
0.113 0.015
0.054 0.007
0.281 0.059
0.161 0.017
0.046 0.006
0.149 0.009
0.164 0.016
0.124 0.008
0.48r
0.51 0.06"
0.235 0.049
Lactate 0
7.5
45
120
(5)
(7)
(7)
(3)
18.3 1.1
23.7 3.0
23.7 3.0
29.4 4.3
15.6 3.0
18.6 2.4
18.7 2.0
23.0 1.3
11.6 1.6
16.6 1.5
16.2 1.6
22.4 4.9
10.1 0.4
13.9 1.3
17.0 3.3
21.7 3.3
23.1 2.0
29.9 3.5
43.4 4.6
53.6 1.5
22.5 1.5
33.3 3.5
41.5 4.0
57.7 0.9
The levels are all recorded as mmole kg' (dry wt.) S.E. for the number of kidneys in parenthesis unless noted. Three to ten samples (usually
5) of each nephron segment of each animal were analyzed. The figures at 7.5 sec consist of pooled data for S and 10 sec of ischemia. They have
been combined because there were few significant differences between the two groups, and interpretation became easier with a larger number of
kidneys represented. For the same reason, data for kidneys exposed to 30 and 60 sec of ischemia have been combined to give the 45 sec values.
One kidney at 10 sec
b One kidney at 30 sec
One kidney
"Two kidneys
P
6
4
2
0
Fig. 3. Effect of ischemia on phosphocreatine in 6 parts of the nephron
and in the papilla. Symbols are the same as in Fig. 2.
1% in PST. In contrast, glycogen contributed almost 30% of the
total in TAL and papilla.
Glucose-6-phosphate and lactate
These two metabolites are considered together since the rate
of change in lactate is a measure of the flux on the glycolytic
Fig. 4. Effect of ischemia on glycogen levels in 5 parts of the nephron
and in the papilla. Concentrations are given as glycosyl units, mmol
kg' (dry wt). Symbols are the same as in Fig. 2.
pathway below glucose-6-phosphate, and changes in glucose-6-
phosphate combined with a knowledge of the flux can be used
to assess changes in degree of control being exercised at the
phosphofructokinase step.
Control levels. As reported earlier [17], highest control glu-
Time, sec Time, sec
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cose-6-phosphate levels are in the glomerulus and the late
portion of the PST (Fig. 6, Table 2). Lactate concentrations
ranged twofold from lowest levels in the PST and highest in
TAL and PAP (Fig. 7, Table 2).
Changes with ischemia. Glucose-6-phosphate decreased in
all structures with ischemia but by different amounts and rates
(Fig. 5, Table 2). The TAL and late PST (PSTL) levels fell most
rapidly at first, and they continued to fall at a rapid rate in the
PSTL but not in the TAL. The greatest change in 120 seconds
occurred in the PST (—87%). Elsewhere the decreases ranged
from 67% in the glomerulus to 27% in PAP.
Lactate increases with ischemia differed sharply in absolute
terms between the proximal and distal structures, but less so
percentage—wise (Fig. 7, Table 2). The increments in the
glomerulus, PCT, and PST were only 7 to 12 mmol . kg'. The
increments in TAL and papilla were much greater, 30 and 35
mmol. kg', respectively.
Fig. 7. Effect of ischemia on lactate levels in 4 parts of the nephron
and in the papilla. Symbols are the same as in Fig. 2.
The rise in lactate during ischemia should approximate the
fall in glucose plus glycogen (two lactates per glucosyl unit). A
test of this, with the 120 second data, showed good agreement
in two cases: for PST 11.2 mmol - kg lactate observed, 9.7
mmol. kg' calculated; for papilla 35 mmol . kg lactate ob-
served, 34 mmol kg' calculated. However, in the other
regions, lactate calculated was decidedly more than found: 70%
too high in TAL and three times too high in PCT and
glomerulus.
In both glomerulus and PCT, the discrepancies amount to
only about 25% of the initial glucose content. It seems possible
that when the blood supply is cut off and capillary pressure
falls, enough capillary blood and glomerular fluid, both high in
glucose, may leave the glomerulus to account for the discrep-
ancy. Similarly, it is conceivable that in the PCT, which is the
segment most active in glucose transport, this function may
continue long enough to transfer a substantial amount of
glucose into the interstitial space.
High energy phosphate consumption. During complete ische-
mia, that is, with oxidation blocked and no metabolite washout,
it is possible to approximate the high energy phosphate (—P)
consumption ("metabolic rate") from the decreases in ATP and
phosphocreatine and the increase in lactate [201. Figure 8
records this calculation for the rate during the first 7.5 seconds
of ischemia. The assumption is made that lactate came exclu-
sively from glucose, generating 1 mol of —P per mole, and that
(as calculated from whole kidney data reported in [21]) the
dephosphorylated ATP went 80% to AMP and 20% to ADP,
that is, 1.8 mole of —P per mole of ATP decrease. These
estimates probably err somewhat on the low side because no
allowance has been made for a contribution from nucleotide
triphosphates other than ATP, and any lactate generated from
glycogen would yield 1.5 mol —P per mole of glucosyl units.
The proximal tubule segments had about the same calculated
—P consumption rate as the TAL, but 67 to 80% came from
ATP breakdown, whereas in the TAL only 50% came from ATP
with nearly an equal proportion from glycolysis. It is probable
that the highest —P use was in the DCT, but reliable lactate data
are not available. The lowest —P use was in the glomerulus
Time, sec Time, sea
Fig. S. Effect of ischemia on glucose levels in 6 parts of the nephron
and in the papilla. Symbols are the same as in Fig. 2.
Time, sec
Fig. 6. Effect of ischemia on glucose-6-phosphate levels in 4 parts of
the nephron and in the papilla. Symbols are the same as in Fig. 2.
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followed by the PAP, with no significant contribution during the
first 7.5 seconds from ATP or phosphocreatine in either struc-
ture.
Figure 8 also shows the 02 consumption equivalent to the —P
use. This is simply based on a PlO ratio of 3 and has been
calculated on a wet weight basis, assuming a 1 to 5 ratio
between dry and wet mass. Nishiitsutsuji—Uwo, Ross and
Krebs [22] observed an 02 consumption of about 5 mmol . kg'
(wet) min' for perfused rat kidney. This agrees surprisingly
well with the (probably slightly low) estimates of Figure 8 and
suggests that the in vivo metabolic rate is maintained for a brief
period after the blood supply is cut off.
Discussion
The present results with defined segments of the nephron are
quite compatable with earlier data on the effects of ischemia on
whole kidney and kidney cortex [21, 23], and on sequential
thick tangential—slices of quick frozen kidneys [181. Similarly,
the relatively slow fall in ATP in papilla reported here confirms
the finding of Jones and Welt [24]. The approximate agreement
of calculated —P consumption with that corresponding to
oxygen consumption in vivo makes it likely that the data for the
individual nephron portions reflects the in vivo metabolic rate.
On this assumption, the metabolic rate in the glomerulus is only
about a third that of the proximal tubule segments, and
glycolysis was sufficient to maintain the ATP level for at least 45
seconds of ischemia, as was also true for the papilla.
The similar rates of —P consumption in different tubule
segments (with the probable exception of the DCT) in spite of
differing sources of energy, agrees with earlier macro slice data
[18]. In that study it was shown that slices from the outer and
inner half of the kidney consumed during 30 seconds similar
amounts of —P. but the outer slices had used much more ATP
and phosphocreatine, the inner slices had produced more
lactate, giving a calculated —P consumption that was similar in
all slices.
Since brain and kidney have similar metabolic rates, it may
be useful to compare the metabolic changes with ischemia in the
two organs. In mouse brain [20] ATP fell only about 10% during
P the first 7.5 seconds of isehemia, as compared to a 60% drop in
kidney PCT and PST. Nevertheless, the calculated —P con-
sumption was similar because in brain there was a 35% drop in
phosphocreatine and a 65% increase in lactate, whereas in PCT
and PST the contributions to —P consumption were small from
lactate formation and almost nil from phosphocreatine.
The A TP, creatine phosphate system. Creatine phosphate has
received almost no attention in kidney, probably because the
level in whole kidney is low compared to muscle and brain.
Attempts to measure phosphocreatine in whole kidney in vivo
with NMR have failed because of the difficulty in avoiding
signals from the exceedingly high levels of phosphocreatine in
adjacent muscle [25]. Measurements have been made with
isolated perfused rat kidney. Phosphocreatine signals were
observed at just above the limit of detection (equivalent to 1 to
2 mmol per kg dry weight) [25, 26]. This is not far below what
might be expected from the present in vivo data, considering
the fact that segments with high levels are diluted with segments
with very low levels and the fact that NMR only detects "free
phosphocreatine." Low levels in many tissues have been
dismissed as probably due to the presence of vascular smooth
muscle. Gerlach, Bader, and Schwoerer [21] found a level of
about 0.4 mmol - kg' wet weight (2 mmol- kg' dry wt in rat
kidney) and attributed this to blood vessel smooth—muscle. This
could be the source of the phosphocreatine in the glomeruli and
papilla, but cannot explain the levels in the cleanly—dissected
tubule segments. The present finding of a high level in the DCT
and a substantial level in the PCT increases interest in this high
energy phosphate reserve. (The DCT level approaches that of
normal brain.)
The equilibrium constant for the creatine kinase system
strongly favors ATP formation. In keeping with this, it has long
been known, from studies of brain and muscle, that phospho-
creatine falls before ATP when high—energy phosphate genera-
tion fails to meet demand (ischemia, severe exercise, etc.). It
therefore comes as a surprise that in the kidney segments,
especially the PCT, ATP falls faster and further than
phosphocreatine. A possible explanation is the relatively low
level of creatine kinase compared to brain and muscle. The
activity in DCT is only about 5% of that in skeletal muscle [27],
and the PCT activity is lower still, by a factor of 100.
In any case, the fact that phosphocreatine is present at
substantial levels in certain parts of the nephron, but is not an
immediately available emergency source of high energy phos-
phate, suggests that it may have some other role in these
regions. For example, phosphocreatine is known to be an
inhibitor of both brain and muscle phosphofructokinase, a key
control enzyme of the glycolytic pathway [28, 29].
Carbohydrate reserves. The only major energy reserves in
kidney, besides nucleoside triphosphates and phosphocreatine,
are glycogen and glucose. As seen, glycogen levels in the
proximal tubule are almost negligible, whereas glucose levels
are substantial—roughly equivalent to blood levels. In contrast,
distal structures contain major concentrations of both glycogen
and glucose. The glycogen levels approximate those of mouse
brain [201, but are only about 10% of those of rat skeletal muscle
[12] and 1% of those in liver [30]. However, the results show
120
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Fig. 8. Calculated high energy phosphate consumption for the first 7.5
seconds of ischemia in different parts of the nephron andinpapilla. The
assumptions on which the calculations are based are given in the text,
including the conversion of —P to equivalent 02 consumption.
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that even where glycogen is relatively high it is not readily
available during ischemia. For example, in the TAL after two
minutes glucose was almost gone, whereas 65%of the glycogen
remained. Glycogen phosphorylase data are not available for
nephron segments, but Delaval et al [311 found activities of 200
and 300 mmol• kg (dry wt) h in rat kidney cortex and
medulla, respectively. These values are 10% or less of the levels
in fast twitch skeletal muscles, but are a third or more of levels
in brain. Both of these are tissues which can mobilize their
glycogen reserves rapidly during ischemia (brain) or with in-
tense stimulation (muscle).
Thus lactate during brief ischemia comes chiefly from glu-
cose, and as expected from regional studies and enzyme distri-
bution data, the increases were much more rapid in distal than
in proximal structures. The most relevant study is that of
Bagnasco et al [4] who measured lactate production in isolated
tubules with oxidation blocked by antimycin A. Highest activity
was observed in (medullary) TAL, with almost zero production
in proximal segments. The present results are in agreement,
except that a significant increase in lactate was observed in the
PST segments; the average for the first 45 seconds was 25% of
that formed in TAL. The rate in TAL for the first 45 seconds
was 27 mmol kg (dry wt) min' (27 pmol sg' min). On
the basis of a dry weight for rat TAL of 0.188 g. mm
(unpublished data of Dr. Helen B. Burch), this is a rate of
5.1 pmol . mm . min. This agrees surprisingly well with
Bagnasco et al [4] who found an average of 5.4
pmol . mm' . min in their study.
Glucose-6-phosphate decreased with ischemia in every re-
gion examined, except possibly the papilla. Hems and Brosnan
observed a similar decrease in whole kidney, whereas in liver,
they found that glucose-6-phosphate increased with ischemia
[23]. They attributed the difference to the "absence in kidney of
major glycogen stores." Actually, whether glucose-6-
phosphate goes up or down with increased flux depends on the
balance between activation of hexokinase and phosphorylase
and availability of glycogen on one side, and activation of
phosphofructokinase on the other. It is clear that in this case
phosphofructokinase activation was sufficient in all parts of the
nephron to more than compensate for an increase in glucose-6-
phosphate formation. As noted, the time course for glucose-6-
phosphate in TAL was exceptional in that after a very rapid fall
during the first 5 or 10 seconds, there was almost no further
change for the full two minutes, during which time lactate
continued to accumulate. This probably indicates that
phosphofructokinase was initially activated more rapidly than
hexokinase (and phosphorylase), whereas after the first few
seconds the activation of hexokinase was sufficient to maintain
a relatively high, steady—state glucose-6-phosphate level. It is
significant that the same phenomenon of a rapid fall in glucose-
6-phosphate followed by a plateau was observed in mouse brain
during ischemia [20].
This study may help explain why the distal tubule is more
resistant to ischemia than the proximal [32]. After two minutes
of ischemia both TAL and DCT had more residual ATP than the
proximal segments and TAL, at least, had 75% of its relatively
high glycogen reserve remaining. The proximal segments still
had substantial glucose residues, but their capacity to use it is
very poor.
Whether or not this speculation has validity, it does not help
to explain why during anoxia with continuing filtration (in
contrast to ischemia) the TAL is selectively damaged. Since
this damage is prevented by blocking filtration or by giving
inhibitors of Na transport [5], the first guess would be that the
damage is due to continuing expenditure of —P for Na transport
in spite of the 02 lack, A problem with this explanation is the
paradoxical finding that addition to the perfusion fluid of
inhibitors of the electron transport chain lessens TAL damage
[33]. These additives lowered the perfusion rate, which should
be protective, but they also lowered ATP levels in the whole
medulla, which should be harmful, provided that the TAL
shared in this general fall in ATP. However, this is not
necessarily true. The TAL have a substantial glycogen reserve,
as well as high levels of glycolytic enzymes, including
hexokinase (note in Table 2 the high rate of lactate production.)
This should make them less dependent on oxidative metabolism
than the proximal tubules, and therefore able to survive with
the extra aid from the decrease in perfusion. To settle this
question, it should be useful to examine high energy phosphate
compounds and metabolites in the TAL itself, during hypoxic
perfusion experiments.
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